Mice Model Industry News

The report "Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030", is projected to reach USD 2.74 billion by 2030 from USD 1.70 billion in 2025, at a CAGR of 10.0% during the forecast period.

Browse 576 market data Tables and 54 Figures spread through 446 Pages and in-depth TOC on "Mice Model Market - Global Forecast to 2030"

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html

The mice model market is experiencing strong growth due to several contributing factors. These include the expanding use of mice in preclinical research because of their genetic and physiological similarities to humans, the rising implementation of mouse clinical trials (MCTs), and growing interest in personalized medicine, especially in oncology. Additionally, innovations in genetic engineering, such as CRISPR and increasing demand for disease-specific models, are expected to accelerate market growth during the forecast period.

By model type, the inbred mice segment accounted for the largest share of the market in 2024.

The market is categorized by model type into inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. In 2024, the inbred mice segment accounted for the largest share of the market. Inbred mice are developed through at least 20 generations of sibling or parent–offspring matings, producing genetically identical strains known as isogenic mice. Their uniform genetic background supports reproducible results across studies and laboratories. These models are used in research areas including pharmacology, carcinogenesis, monoclonal antibody production, tissue grafts, and cardiovascular studies. In behavioral research, inbred mice help isolate genetic influences on traits like memory, anxiety, and social interaction. In oncology, they support investigations into tumor development and therapy response. Their genetic consistency makes them suitable for validating new therapeutic agents, diagnostics, and vaccines.

In 2024, the CRISPR/Cas9 segment accounted for the largest share of the mice model market.

The mice model market is segmented by technology into CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. In 2024, the CRISPR/Cas9 segment accounted for the largest share of the market. This domination of the CRISPR/Cas9 segment can be attributed to its efficient and precise genome editing application. CRISPR/Cas9 systems use short guide RNAs and the Cas9 endonuclease to induce targeted DNA cleavage, enabling gene knockouts, base editing, and transgenesis. This method allows direct gene editing at the single-cell embryo stage, bypassing traditional breeding cycles and reducing timelines for generating modified strains. CRISPR also supports multiplexed editing, allowing simultaneous modification of multiple genes, which streamlines high-throughput in vivo genetic screening. For instance, a study published in Nature in October 2024 demonstrated both in vitro and in vivo CRISPR-Cas9 screening in aged Cas9-expressing mice, identifying over 300 gene knockouts and validating 24 targets for enhanced neurogenesis. Integrating CRISPR systems in transgenic model development and functional genomics has driven adoption among research institutions and pharmaceutical developers, establishing the technology’s leading market position.

By region, North America accounted for the largest market share in 2024.

In 2024, North America accounted for the largest market share of the mice model market, driven by established infrastructure for biomedical research, consistent regulatory oversight, and significant market participants. The US is the primary revenue contributor due to the concentration of contract research organizations, academic research centers, and biotechnology firms. Companies such as Charles River Laboratories (US), The Jackson Laboratory (US), and Inotiv (US) operate large-scale breeding and research facilities across the region, offering comprehensive services that include genetically engineered model development and preclinical testing.

Some of the leading players in the market include Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), Biocytogen (China), Trans Genic Inc. (Japan) Harbour BioMed (China), genOway (France), GemPharmatech (China), Cyagen (US), Ozgene Pty Ltd (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Vivo Bio Tech Ltd (India), ingenious targeting laboratory (US), Janvier Labs (France), Champions Oncology, Inc (US), and Vitalstar Biotechnology Co., Ltd. (China), among others.

Don’t miss out on business opportunities in Mice Model Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/